Annual Operating Expenses
$314.59 M
-$21.11 M-6.29%
December 31, 2023
Summary
- As of February 7, 2025, ALLO annual total operating expenses is $314.59 million, with the most recent change of -$21.11 million (-6.29%) on December 31, 2023.
- During the last 3 years, ALLO annual operating expenses has risen by +$56.34 million (+21.82%).
- ALLO annual operating expenses is now -6.29% below its all-time high of $335.69 million, reached on December 31, 2022.
Performance
ALLO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$61.05 M
-$5.40 M-8.12%
September 30, 2024
Summary
- As of February 7, 2025, ALLO quarterly total operating expenses is $61.05 million, with the most recent change of -$5.40 million (-8.12%) on September 30, 2024.
- Over the past year, ALLO quarterly operating expenses has dropped by -$1.97 million (-3.13%).
- ALLO quarterly operating expenses is now -54.78% below its all-time high of $135.01 million, reached on June 30, 2018.
Performance
ALLO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ALLO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.3% | -3.1% |
| 3 y3 years | +21.8% | -20.4% |
| 5 y5 years | +63.1% | +11.0% |
ALLO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.3% | +6.9% | -38.4% | at low |
| 5 y | 5-year | -6.3% | +55.7% | -38.4% | +5.8% |
| alltime | all time | -6.3% | +63.1% | -54.8% | +2250.6% |
Allogene Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $61.05 M(-8.1%) |
| Jun 2024 | - | $66.44 M(-4.4%) |
| Mar 2024 | - | $69.53 M(-3.3%) |
| Dec 2023 | $314.59 M(-6.3%) | $71.89 M(+14.1%) |
| Sep 2023 | - | $63.02 M(-21.8%) |
| Jun 2023 | - | $80.56 M(-18.7%) |
| Mar 2023 | - | $99.12 M(+2.8%) |
| Dec 2022 | $335.69 M(+14.1%) | $96.42 M(+16.8%) |
| Sep 2022 | - | $82.54 M(+7.6%) |
| Jun 2022 | - | $76.68 M(-4.2%) |
| Mar 2022 | - | $80.05 M(+8.3%) |
| Dec 2021 | $294.28 M | $73.94 M(-4.9%) |
| Sep 2021 | - | $77.72 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $71.07 M(-0.7%) |
| Mar 2021 | - | $71.55 M(+3.1%) |
| Dec 2020 | $258.24 M(+27.8%) | $69.36 M(+1.9%) |
| Sep 2020 | - | $68.04 M(+7.7%) |
| Jun 2020 | - | $63.16 M(+9.5%) |
| Mar 2020 | - | $57.68 M(-10.7%) |
| Dec 2019 | $202.01 M(+4.8%) | $64.58 M(+17.4%) |
| Sep 2019 | - | $55.01 M(+19.7%) |
| Jun 2019 | - | $45.96 M(+26.1%) |
| Mar 2019 | - | $36.46 M(+10.3%) |
| Dec 2018 | $192.84 M | $33.05 M(+48.9%) |
| Sep 2018 | - | $22.19 M(-83.6%) |
| Jun 2018 | - | $135.01 M(+5098.8%) |
| Mar 2018 | - | $2.60 M |
FAQ
- What is Allogene Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Allogene Therapeutics?
- What is Allogene Therapeutics annual operating expenses year-on-year change?
- What is Allogene Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly operating expenses year-on-year change?
What is Allogene Therapeutics annual total operating expenses?
The current annual operating expenses of ALLO is $314.59 M
What is the all time high annual operating expenses for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total operating expenses is $335.69 M
What is Allogene Therapeutics annual operating expenses year-on-year change?
Over the past year, ALLO annual total operating expenses has changed by -$21.11 M (-6.29%)
What is Allogene Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ALLO is $61.05 M
What is the all time high quarterly operating expenses for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total operating expenses is $135.01 M
What is Allogene Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ALLO quarterly total operating expenses has changed by -$1.97 M (-3.13%)